首页> 外文OA文献 >Development and characterization of an amorphous solid dispersion of furosemide in the form of a sublingual bioadhesive film to enhance bioavailability
【2h】

Development and characterization of an amorphous solid dispersion of furosemide in the form of a sublingual bioadhesive film to enhance bioavailability

机译:速尿无定形固体分散体的开发和特性,以舌下生物粘附膜的形式增强生物利用度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Administered by an oral route, Furosemide (FUR), a diuretic used in several edematous states and hypertension, presents bioavailability problems, reported as a consequence of an erratic gastrointestinal absorption due to various existing polymorphic forms and low and pH-dependent solubility. A mucoadhesive sublingual fast-dissolving FUR based film has been developed and evaluated in order to optimize the bioavailability of FUR by increasing solubility and guaranteeing a good dissolution reproducibility. The Differential Scanning Calorimetry (DSC) analyses confirmed that the film prepared using the solvent casting method entrapped FUR in the amorphous state. As a solid dispersion, FUR increases its solubility up to 28.36 mg/mL. Drug content, thickness, and weight uniformity of film were also evaluated. The measured Youngâu80u99s Modulus, yield strength, and relative elongation of break percentage (EB%) allowed for the classification of the drug-loaded film as an elastomer. Mucoadhesive strength tests showed that the force to detach film from mucosa grew exponentially with increasing contact time up to 7667 N/m2. FUR was quickly discharged from the film following a trend well fitted with the Weibull kinetic model. When applied on sublingual mucosa, the new formulation produced a massive drug flux in the systemic compartment. Overall, the proposed sublingual film enhances drug solubility and absorption, allowing for the prediction of a rapid onset of action and reproducible bioavailability in its clinical application.
机译:通过口服途径,速尿(FUR)是一种在几种水肿状态和高血压中使用的利尿剂,存在生物利用度问题,据报道由于各种现有的多晶型形式以及低和pH依赖性的溶解性,导致胃肠道吸收不规律。已经开发并评估了粘膜黏膜舌下速溶FUR基薄膜,以通过增加溶解度并确保良好的溶解再现性来优化FUR的生物利用度。差示扫描量热法(DSC)分析证实,使用溶剂流延法制备的膜截留了非晶态的FUR。作为固体分散体,FUR将其溶解度提高到28.36 mg / mL。还评估了膜的药物含量,厚度和重量均匀性。测得的杨氏模量,屈服强度和断裂伸长率的相对伸长率(EB%)可将载药膜分类为弹性体。粘膜黏附强度测试表明,膜与粘膜分离的力随着接触时间的增加而指数增长,直至达到7667 N / m2。遵循韦伯动力学模型的趋势,FUR迅速从薄膜中排出。当应用在舌下粘膜下时,新配方在全身隔室产生大量药物流。总体而言,拟议中的舌下膜增强了药物的溶解性和吸收性,从而可以预测其临床应用中作用的迅速开始和可再现的生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号